NAUT
Nautilus Biotechnology Inc.
Company Overview
| Mkt Cap | $86.01M | Price | $1.70 |
| Volume | 1.15M | Change | +27.56% |
| P/E Ratio | -1.2 | Open | $1.35 |
| Revenue | -- | Prev Close | $1.33 |
| Net Income | $-70.8M | 52W Range | $0.62 - $2.92 |
| Div Yield | N/A | Target | $2.50 |
| Overall | 49 | Value | 60 |
| Quality | 21 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyNautilus Biotechnology Inc. (NAUT) is a leading Professional, Scientific, and Technical Services company in the Testing Laboratories industry, currently trading at $1.70 with a market capitalization of $86.01 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 21.
Today's trading session shows NAUT with a volume of 1.15 million shares. The stock opened up 1.50% from yesterday's close of $1.33. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
NAUT demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for NAUT include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 47.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 4, 2025 at 05:02 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAUT | $1.70 | +27.6% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Nautilus Biotechnology Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW